BioSpace News Archive

BioArctic AB announced data on the drug candidate lecanemab, which were presented by the company and its partner Eisai at the 15th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, AD/PD™.

Dearth of highly effective treatment approaches combined with the emergence of more intricate forms of lung cancers is prompting companies to initiate research projects and trials to test the efficacy of gemcitabine HCL in this domain

Fast track regulatory approvals granted by government agencies to fuel research prospects is expected to widen the scope for gene therapies in the long run.

Increasing cases of cancer among infants to bolster the sales for pediatric neuroblastoma treatment market

The demand in the global cardiac rehabilitation market is estimated to increment at a significant CAGR of 5.4% during the forecast period of 2016 to 2024, gaining traction from a number a factors, such as rise in geriatric population, growing burden of cardiovascular diseases, and increase in global initiatives regarding the awareness for cardiovascular diseases.

When there is an imbalance between the production and absorption of cerebrospinal fluid, is known as hydrocephalus.

The global market for cone beam computed tomography is likely to observe a strong competition among the leading players present in the market, states a new research study that has been presented by Transparency Market Research.

The market for dental laboratories is anticipated to experience a tremendous growth in coming years due to rise in prevalence of periodontal diseases.

Business Intelligence platforms enable healthcare organizations to build applications that help them understand their processes and use technology to help ensure healthcare quality and control cost.

The research report on the global hearing aids market offers a comprehensive outlook of the overall market.